Cronos (CRON) Exchange Rate Effect (2019 - 2026)
Cronos' (CRON) quarterly Exchange Rate Effect came in at -$597000.0 in Q1 2026, up 1.16% year-on-year from -$590160.4 in Q1 2025, and down 238.84% quarter-over-quarter from $430000.0 in Q4 2025.
Cronos (CRON) Exchange Rate Effect (2019 - 2026) Analysis & Trends
Cronos' Exchange Rate Effect history runs 8 years deep, the most recent figure standing at -$597000.0 for Q1 2026.
- On a quarterly basis, Exchange Rate Effect rose 1.16% year-over-year to -$597000.0 in Q1 2026; TTM through Mar 2026 was $3.6 million, a 221.13% increase from a year earlier, with the FY2025 full-year figure at $3.6 million, up 210.47% from the prior year.
- Exchange Rate Effect eased to -$597000.0 in Q1 2026 per CRON's latest filing, from $430000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $8.8 million in Q1 2022 and bottomed at -$22.6 million in Q3 2022.
- The 5-year median for Exchange Rate Effect is $148000.0 (2024), against an average of -$1.2 million.
- Across the five-year window, Exchange Rate Effect slumped 555.44% in 2024 and soared 1554.05% in 2025, its largest moves.
- Year by year, Exchange Rate Effect stood at -$2.1 million in 2022, then jumped by 59.63% to -$855000.0 in 2023, then slumped by 555.44% to -$5.6 million in 2024, then jumped by 107.67% to $430000.0 in 2025, then tumbled by 238.84% to -$597000.0 in 2026.
- Per Business Quant, the three latest CRON Exchange Rate Effect figures stand at -$597000.0 (Q1 2026), $430000.0 (Q4 2025), and $1.3 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -17.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 17.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 7.01 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -4.20 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -5.00 Mn |
| 10 | Cronos | 1.04 Bn | 267.78 Mn | 19.15 Mn | -597,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -597,000.00 |
| Mar 31, 2026 | -597,000.00 |
| Dec 31, 2025 | 430,000.00 |
| Dec 31, 2025 | 430,000.00 |
| Sep 30, 2025 | 1.31 Mn |
| Sep 30, 2025 | 1.31 Mn |
| Jun 30, 2025 | 2.45 Mn |
| Jun 30, 2025 | 2.45 Mn |
| Mar 31, 2025 | -604,000.00 |
| Mar 31, 2025 | -604,000.00 |
| Dec 31, 2024 | -5.60 Mn |
| Dec 31, 2024 | -5.60 Mn |
| Sep 30, 2024 | 3.09 Mn |
| Sep 30, 2024 | 3.09 Mn |
| Jun 30, 2024 | 148,000.00 |
| Jun 30, 2024 | 148,000.00 |
| Mar 31, 2024 | -884,000.00 |
| Mar 31, 2024 | -884,000.00 |
| Dec 31, 2023 | -855,000.00 |
| Dec 31, 2023 | -855,000.00 |